Overview of Dr. Hanash
Dr. Alan Hanash is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 11 years. Dr. Hanash accepts several types of health insurance, listed below. He is one of 495 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 50 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2012
University of ChicagoResidency, Internal Medicine, 2006 - 2008
University of Miami Leonard M. Miller School of MedicineClass of 2006
Certifications & Licensure
NY State Medical License 2008 - 2025
IL State Medical License 2006 - 2009- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 67 citationsNational Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.Daniel Wolff, Vedran Radojcic, Robert Lafyatis, Resat Cinar, Rachel K. Rosenstein
Transplantation and Cellular Therapy. 2021-10-01 - 92 citationsHigh day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantationDoris M. Ponce, Patrick Hilden, Christen L. Mumaw, Sean M. Devlin, Marissa Lubin
Blood. 2015-01-01 - 452 citationsInterleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.Alan M. Hanash, Jarrod A Dudakov, Guoqiang Hua, Margaret O'Connor, Lauren F. Young
Immunity. 2012-08-24
Abstracts/Posters
- Graft Versus Host Disease Leads to Elimination of Tissue-Resident Innate Lymphoid Cells Following Experimental and Clinical Allogeneic TransplantationAlan M. Hanash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Mitochondrial Complex II in Intestinal Epithelial Cells Is a Critical Metabolic Checkpoint That Regulates Severity of Gastrointestinal Graft-Versus-Host DiseaseAlan M. Hanash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Insurance Accepted
- United Healthcare - Direct Choice Plus POSUnited Healthcare - Direct Options PPO
- Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
